Pediatric Psychotropic Use

Read Our Reports:

Pediatric Psychotropic Use Report and Recommendations (Adopted November 2016)

Among psychotropic medications prescribed to pediatric patients, antipsychotics have great potential for overuse. These drugs are often prescribed for aggressive or impulsive behaviors rather than psychosis and are associated with patient harms in a developing brain. The Report and Recommendations suggests strategies to improve appropriateness of antipsychotic drug prescribing to pediatric patients supported by behavioral health services. The workgroup met from January to November 2016.

Supporting Materials:

Letter from Health Care Authority Accepting Pediatric Psychotropic Use Report and Recommendations
Pediatric
Psychotropic Use Charter

Member Title Organization
Shelley Dooley Parent Advocate
Nalini Gupta MD Pediatrician Developmental and Behavioral Pediatrics
Providence Health and Services
Robert Hilt MD Director, Community Leadership; Director of Partnership Access Line Seattle Children’s
Paula Lozano MD, MPH (Chair) Medical Director, Research and Translation Group Health Cooperative
Liz Pechous PhD Clinical Director ICARD, PLLC
Robert Penfold PhD Co-investigator, Mental Health Research Network Group Health Research Institute
James Polo MD MBA Chief Medical Officer Western State Hospital
David Testerman PharmD Pharmacy Director Amerigroup
Mark Stein PhD, ABPP Director of ADHD and Related Disorders Seattle Children’s
Donna Sullivan PharmD, MS Chief Pharmacy Officer Washington Health Care Authority